Total Payments
$10,639
2023 Payments
$32.55
Companies
35
Transactions
718
Medicare Patients
21,087
Medicare Billing
$4.2M
Payment Breakdown by Category
Food & Beverage$10,632 (99.9%)
Education$7.45 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,632 | 717 | 99.9% |
| Education | $7.45 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,281 | 143 | $0 (2022) |
| Amgen Inc. | $1,518 | 103 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $1,072 | 70 | $0 (2022) |
| Genentech USA, Inc. | $903.85 | 81 | $0 (2021) |
| PFIZER INC. | $644.86 | 62 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $604.10 | 37 | $0 (2022) |
| Janssen Biotech, Inc. | $569.19 | 51 | $0 (2023) |
| UCB, Inc. | $352.89 | 30 | $0 (2022) |
| GlaxoSmithKline, LLC. | $348.15 | 20 | $0 (2022) |
| Radius Health, Inc. | $257.25 | 17 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $32.55 | 2 | Janssen Biotech, Inc. ($16.72) |
| 2022 | $1,845 | 85 | ABBVIE INC. ($641.72) |
| 2021 | $2,022 | 128 | AbbVie Inc. ($497.21) |
| 2020 | $1,085 | 72 | AbbVie Inc. ($343.49) |
| 2019 | $1,715 | 110 | Novartis Pharmaceuticals Corporation ($263.22) |
| 2018 | $2,007 | 151 | AbbVie, Inc. ($350.55) |
| 2017 | $1,932 | 170 | Genentech USA, Inc. ($335.95) |
All Payment Transactions
718 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/15/2023 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 06/28/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Immunology | ||||||
| 12/15/2022 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI ARIA | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Immunology | ||||||
| 11/28/2022 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI ARIA | Food and Beverage | In-kind items and services | $12.48 | General |
| Category: Immunology | ||||||
| 10/03/2022 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI ARIA | Food and Beverage | In-kind items and services | $12.48 | General |
| Category: Immunology | ||||||
| 09/29/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2022 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $16.37 | General |
| Category: Immunology | ||||||
| 09/16/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: IMMUNOLOGY | ||||||
| 09/14/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2022 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $11.03 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2022 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $0.70 | General |
| Category: IMMUNOLOGY | ||||||
| 09/06/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: IMMUNOLOGY | ||||||
| 09/06/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: KRYSTEXXA | ||||||
| 08/31/2022 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $27.33 | General |
| Category: Inflammation | ||||||
| 08/30/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: Bone Health | ||||||
| 08/24/2022 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/23/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: IMMUNOLOGY | ||||||
| 08/22/2022 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $16.37 | General |
| Category: Immunology | ||||||
| 08/18/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: IMMUNOLOGY | ||||||
| 08/17/2022 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Inflammation | ||||||
| 08/15/2022 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: IMMUNOLOGY | ||||||
| 08/10/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: IMMUNOLOGY | ||||||
| 08/02/2022 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/02/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Bone Health | ||||||
| 07/27/2022 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI ARIA | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 35 | 5,884 | 41,311 | $1.9M | $944,002 |
| 2021 | 38 | 6,999 | 51,129 | $3.0M | $1.5M |
| 2020 | 45 | 8,204 | 57,205 | $3.7M | $1.8M |
Total Patients
21,087
Total Services
149,645
Medicare Billing
$4.2M
Procedure Codes
118
All Medicare Procedures & Services
118 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2022 | 19 | 7,375 | $464,625 | $254,263 | 54.7% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 132 | 9,360 | $262,080 | $157,217 | 60.0% |
| J9312 | Injection, rituximab, 10 mg | Office | 2022 | 14 | 2,020 | $232,300 | $133,806 | 57.6% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2022 | 33 | 4,390 | $329,250 | $122,372 | 37.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 519 | 927 | $133,488 | $73,192 | 54.8% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2022 | 13 | 7,350 | $97,020 | $54,935 | 56.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 261 | 484 | $46,464 | $26,714 | 57.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 138 | 165 | $31,350 | $19,484 | 62.1% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 59 | 168 | $37,800 | $16,382 | 43.3% |
| 86235 | Measurement of antibody for assessment of autoimmune disorder, any method | Office | 2022 | 88 | 792 | $30,096 | $13,937 | 46.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 486 | 985 | $39,400 | $10,209 | 25.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 588 | 1,206 | $24,120 | $9,174 | 38.0% |
| 82306 | Vitamin d-3 level | Office | 2022 | 181 | 214 | $35,631 | $6,223 | 17.5% |
| 82550 | Creatine kinase (cardiac enzyme) level, total | Office | 2022 | 471 | 965 | $17,370 | $6,187 | 35.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 223 | 279 | $19,530 | $4,610 | 23.6% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 25 | 93 | $9,486 | $4,558 | 48.1% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 132 | 132 | $33,000 | $4,525 | 13.7% |
| 84550 | Uric acid level, blood | Office | 2022 | 471 | 962 | $16,354 | $4,282 | 26.2% |
| 85651 | Red blood cell sedimentation rate, to detect inflammation, non-automated | Office | 2022 | 526 | 997 | $14,955 | $4,176 | 27.9% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2022 | 35 | 175 | $8,925 | $3,652 | 40.9% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2022 | 222 | 278 | $8,340 | $2,467 | 29.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 146 | 208 | $6,032 | $2,216 | 36.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 398 | 660 | $3,960 | $1,952 | 49.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 25 | 42 | $4,200 | $1,693 | 40.3% |
| 86225 | Measurement of dna antibody, native or double stranded | Office | 2022 | 87 | 97 | $2,910 | $1,308 | 44.9% |
About Dr. Robert Phillips, MD
Dr. Robert Phillips, MD is a Rheumatology healthcare provider based in Huntsville, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841218161.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Phillips, MD has received a total of $10,639 in payments from pharmaceutical and medical device companies, with $32.55 received in 2023. These payments were reported across 718 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($10,632).
As a Medicare-enrolled provider, Phillips has provided services to 21,087 Medicare beneficiaries, totaling 149,645 services with total Medicare billing of $4.2M. Data is available for 3 years (2020–2022), covering 118 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Huntsville, AL
- Active Since 07/17/2006
- Last Updated 09/24/2014
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1841218161
Products in Payments
- COSENTYX (Biological) $1,027
- RINVOQ (Biological) $909.74
- Enbrel (Biological) $847.59
- Humira (Biological) $727.73
- Rituxan (Biological) $623.43
- XELJANZ (Drug) $563.88
- ORENCIA (Biological) $511.58
- Cimzia (Drug) $352.89
- ACTHAR (Biological) $347.28
- SIMPONI ARIA (Biological) $330.22
- RINVOQ (Drug) $291.95
- Actemra (Biological) $280.42
- Tymlos (Biological) $257.25
- BENLYSTA (Biological) $234.52
- EVENITY (Biological) $229.88
- Otezla (Drug) $157.97
- TREMFYA (Drug) $155.32
- Horizant (Drug) $155.06
- SKYRIZI (Biological) $151.08
- LUPKYNIS (Drug) $148.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Huntsville
Dr. William Shergy, Md, MD
Rheumatology — Payments: $257,107
Rheumatology $257,107
Dr. Deepak Sree, Md, MD
Rheumatology — Payments: $19,520
Rheumatology $19,520
Dr. Anil Warrier, M.d, M.D
Rheumatology — Payments: $12,511
Rheumatology $12,511
Dr. Ayesha Jaleel, M.d, M.D
Rheumatology — Payments: $11,554
Rheumatology $11,554
Dr. Margaret Meehan, Md, MD
Rheumatology — Payments: $10,146
Rheumatology $10,146
Dr. Roxanna Sabghi, M.d, M.D
Rheumatology — Payments: $8,286
Rheumatology $8,286